184 related articles for article (PubMed ID: 31514489)
21. Association between serum soluble receptor for advanced glycation end-products (RAGE) deficiency and severity of clinicopathologic evidence of canine chronic inflammatory enteropathy.
Cabrera-García AI; Suchodolski JS; Steiner JM; Heilmann RM
J Vet Diagn Invest; 2020 Sep; 32(5):664-674. PubMed ID: 32715975
[TBL] [Abstract][Full Text] [Related]
22. Circulating concentrations of soluble receptor for AGE are associated with age and AGER gene polymorphisms in children with newly diagnosed type 1 diabetes.
Salonen KM; Ryhänen SJ; Forbes JM; Härkönen T; Ilonen J; Laine AP; Groop PH; Knip M;
Diabetes Care; 2014 Jul; 37(7):1975-81. PubMed ID: 24742661
[TBL] [Abstract][Full Text] [Related]
23. Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies.
Pertyńska-Marczewska M; Głowacka E; Sobczak M; Cypryk K; Wilczyński J
Am J Reprod Immunol; 2009 Feb; 61(2):175-82. PubMed ID: 19143681
[TBL] [Abstract][Full Text] [Related]
24. Changes in circulating levels of carboxymethyllysine, soluble receptor for advanced glycation end products (sRAGE), and inflammation markers in women during normal pregnancy.
Quintanilla-García CV; Uribarri J; Fajardo-Araujo ME; Barrientos-Romero JJ; Romero-Gutiérrez G; Reynaga-Ornelas MG; Garay-Sevilla ME
J Matern Fetal Neonatal Med; 2019 Dec; 32(24):4102-4107. PubMed ID: 29804482
[No Abstract] [Full Text] [Related]
25. Markers of immune-mediated inflammation in the brains of young adults and adolescents with type 1 diabetes and fatal diabetic ketoacidosis. Is there a difference?
Hoffman WH; Artlett CM; Boodhoo D; Gilliland MGF; Ortiz L; Mulder D; Tjan DHT; Martin A; Tatomir A; Rus H
Exp Mol Pathol; 2017 Jun; 102(3):505-514. PubMed ID: 28533125
[TBL] [Abstract][Full Text] [Related]
26. Advanced glycation end products and their receptors did not show any association with body mass parameters in metabolically healthy adolescents.
Garay-Sevilla ME; Torres-Graciano S; Villegas-Rodríguez ME; Rivera-Cisneros AE; Wrobel K; Uribarri J
Acta Paediatr; 2018 Dec; 107(12):2146-2151. PubMed ID: 29846968
[TBL] [Abstract][Full Text] [Related]
27. Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.
Thomas MC; Woodward M; Neal B; Li Q; Pickering R; Marre M; Williams B; Perkovic V; Cooper ME; Zoungas S; Chalmers J; Hillis GS;
Diabetes Care; 2015 Oct; 38(10):1891-7. PubMed ID: 26253728
[TBL] [Abstract][Full Text] [Related]
28. Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?
Prasad K
Mol Cell Biochem; 2019 Jan; 451(1-2):139-144. PubMed ID: 29961210
[TBL] [Abstract][Full Text] [Related]
29. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
Yamagishi S; Matsui T; Nakamura K
Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
[TBL] [Abstract][Full Text] [Related]
30. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
[TBL] [Abstract][Full Text] [Related]
31. Soluble receptor for advanced glycation end products as a vasculopathy biomarker in sickle cell disease.
Safwat NA; Kenny MA
Pediatr Res; 2018 Dec; 84(6):869-874. PubMed ID: 30367158
[TBL] [Abstract][Full Text] [Related]
32. [Changes of lactate levels in diabetic ketoacidosis and in newly diagnosed type 1 diabetes mellitus].
Jenei K; Szatmári I; Szabó E; Mariam A; Luczay A; Zsidegh P; Tóth-Heyn P
Orv Hetil; 2019 Nov; 160(45):1784-1790. PubMed ID: 31680540
[TBL] [Abstract][Full Text] [Related]
33. Association Between Soluble Receptor for Advanced Glycation End Product and Endogenous Secretory Soluble Receptor for Advanced Glycation End Product Levels and Carotid Atherosclerosis in Diabetes: A Systematic Review and Meta-Analysis.
Wang X; Wang Q; Wei D; Chang X
Can J Diabetes; 2021 Oct; 45(7):634-640. PubMed ID: 33773934
[TBL] [Abstract][Full Text] [Related]
34. Advanced glycation end products and glycosaminoglycans in patients with diabetic ketoacidosis.
Edriss H; Molehin AJ; Selvan K; Gavidia R; Patel PU; Nugent K
J Investig Med; 2020 Mar; 68(3):738-742. PubMed ID: 31672720
[TBL] [Abstract][Full Text] [Related]
35. Divergent Changes in Plasma AGEs and sRAGE Isoforms Following an Overnight Fast in T1DM.
Miranda ER; Fuller KNZ; Perkins RK; Beisswenger PJ; Farabi SS; Quinn L; Haus JM
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781793
[TBL] [Abstract][Full Text] [Related]
36. [Modern aspects of diabetic ketoacidosis treatment in children].
Petriaĭkina EE; Lukovenkov AV; Semenova NA; Koltunov IE; Petriaĭkin AV; Varfolomeev SD
Anesteziol Reanimatol; 2012; (3):62-7. PubMed ID: 22993929
[TBL] [Abstract][Full Text] [Related]
37. Audit of diabetic ketoacidosis management at a tertiary hospital in Johannesburg, South Africa.
Thomas S; Mohamed NA; Bhana S
S Afr Med J; 2019 May; 109(6):407-411. PubMed ID: 31266558
[TBL] [Abstract][Full Text] [Related]
38. Morbidity and mortality of diabetic ketoacidosis with and without insulin pump care.
Realsen J; Goettle H; Chase HP
Diabetes Technol Ther; 2012 Dec; 14(12):1149-54. PubMed ID: 23009106
[TBL] [Abstract][Full Text] [Related]
39. Incidence of type 1 diabetes mellitus during 26 years of observation and prevalence of diabetic ketoacidosis in the later years.
Wojcik M; Sudacka M; Wasyl B; Ciechanowska M; Nazim J; Stelmach M; Starzyk JB
Eur J Pediatr; 2015 Oct; 174(10):1319-24. PubMed ID: 25894913
[TBL] [Abstract][Full Text] [Related]
40. Relationship between serum-soluble receptor for advanced glycation end products (sRAGE) and disease activity in rheumatoid arthritis patients.
Jafari Nakhjavani MR; Jafarpour M; Ghorbanihaghjo A; Abedi Azar S; Malek Mahdavi A
Mod Rheumatol; 2019 Nov; 29(6):943-948. PubMed ID: 30474471
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
